Caraco Pharmaceutical Laboratories (CPD) 10-Q 2009 Q3 Quarterly report

EXHIBIT 32.1

CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the accompanying Quarterly Report on Form 10-Q of Caraco Pharmaceutical Laboratories, Ltd. (“Caraco”) for the period ended December 31, 2008 (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of their respective knowledge and belief, that:

(1)          The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)          The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Caraco.

Date: February 2, 2009	/s/ Daniel H. Movens
	Daniel H. Movens
	Chief Executive Officer
Date: February 2, 2009	/s/ Mukul Rathi
	Mukul Rathi
	interim Chief Financial Officer

40